Graphene Investments SAS’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Buy |
6,800
+1,300
| +24% | +$579K | 1.97% | 25 |
|
|
2025
Q1 | $2.67M | Sell |
5,500
-1,000
| -15% | -$485K | 1.95% | 32 |
|
|
2024
Q4 | $2.62M | Sell |
6,500
-600
| -8% | -$242K | 1.81% | 41 |
|
|
2024
Q3 | $3.3M | Hold |
7,100
| – | – | 2.12% | 13 |
|
|
2024
Q2 | $3.33M | Sell |
7,100
-1,100
| -13% | -$516K | 2.09% | 17 |
|
|
2024
Q1 | $3.43M | Hold |
8,200
| – | – | 2.07% | 19 |
|
|
2023
Q4 | $3.34M | Sell |
8,200
-800
| -9% | -$326K | 2.16% | 6 |
|
|
2023
Q3 | $3.13M | Hold |
9,000
| – | – | 2.2% | 5 |
|
|
2023
Q2 | $3.17M | Sell |
9,000
-1,200
| -12% | -$422K | 2.09% | 16 |
|
|
2023
Q1 | $3.21M | Buy |
10,200
+600
| +6% | +$189K | 2.15% | 9 |
|
|
2022
Q4 | $2.77M | Buy |
+9,600
| New | +$2.77M | 1.88% | 36 |
|